Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief
Rob Brown to continue serving as a member of the Board of Directors and as a special advisor to the Company......
Salarius Pharmaceuticals Presents SP-3164 Preclinical Data
Preclinical data show synergistic activity for the targeted protein degrader SP-3164 with rituximab in non-Hodgkin’s lymphomas, and significantly better......
